The patient’s prothrombin time-international normalized ratio (PT-INR) was elevated (2.3; normal range: 0.8-1.2) with a normal activated partial thromboplastin time (aPTT) and no known preexisting liver disease or use of anticoagulant medications. This evidence concerns the gene F2 and liver disorder.